Certainly not a fan boy rather realistic about a small and unproven team.
I've adjusted my expectations accordingly given the likely timespan required to get this one over the line.
How many of these funds you've tracked take stakes in AUS listed biopharma plays at early and pre revenue stage? Its the exception to the rule with one or two significant holdings in late stage and already exponential growth generating plays
Where we at?, page-106
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $99.69M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.5¢ | 27.5¢ | $26.78K | 97.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 129224 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 33316 | 6 |
View Market Depth
| Last trade - 11.30am 11/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |